Science Current Events | Science News | Brightsurf.com
 

Lack of a key enzyme dramatically increases resistance to sepsis

April 24, 2006

Findings could lead to new therapeutic approaches to a major disease

According to the new study, the presence of caspase-12, which appears to modulate inflammation and innate immunity in humans, increases the body's "vulnerability to bacterial infection and septic shock" while a deficiency confers strong resistance to sepsis. This new discovery suggests that caspase-12 antagonists could be a potentially useful in the treatment of sepsis and other inflammatory and immune disorders.

The study was published in the April 20 edition of the journal Nature (Volume 440, Number 7087).

Richard Ulevitch, chair of the Scripps Research Immunology Department and an author of the paper, says, "The results of the study make clear that caspase-12 plays a critical role in the elimination of bacterial pathogens, and that a deficiency allows systemic and abdominal infections to be better resolved. It's known that the presence of caspase-12 as a full length protein occurs in a small percentage of people of African descent. As a result, some of these individuals are far more susceptible to severe sepsis and have a significantly increased risk of dying from it."

Sepsis, the body's inflammatory response to severe infection, is one of the leading causes of death in the United States, killing more than 200,000 people each year, according to the Society of Critical Care Medicine. A 2003 study by The Centers for Disease Control and Emory University School of Medicine showed that the incidence of sepsis in the United States has increased almost nine percent a year since 1979.

The new study showed that caspase-12 deficient mice were resistant to peritonitis and septic shock and were able to clear pathogenic bacteria more efficiently than mice with the enzyme. The presence of caspase-12 also reduced production of several pro-inflammatory cytokines, increasing vulnerability to bacterial infection and septic mortality.

"Without the experimental model of peritonitis perfected by John Mathison from Scripps Research, we would not have been able to differentiate between the two mouse phenotypes," Ulevitch said. "Because of his work, we were able to use a surgically implanted stent in the colon that allowed a gradual occurrence of sepsis and easy identification."

A majority of mice with caspace-12 died from sepsis within the first 48 hours after onset, while 60 percent of the caspase-12 deficient mice survived. The deficient mice also showed a significantly lower number of bacterial colony-forming units per milliliter of blood, suggesting that more efficient bacterial clearance occurs in the absence of caspase-12.

Caspase-12 is also an inhibitor of caspase-1, a related enzyme involved in the inflammation process. Caspase-1 deficient mice are two-to-three times more susceptible to lethal Escherichia coli infection than normal mice. Consequently, the study said, sepsis resistance in caspase-12 deficient mice was most likely due to an initial hyper-production of cytokines that fight the infection.

"The resulting beneficial effect of cytokine hyper-production runs contrary to some of the current thinking in sepsis research," Ulevitch said. "The general thinking is that this initial cytokine 'storm' is harmful, and that belief has been the basis of a number of unsuccessful clinical studies. In our study, cells containing caspase-12 appear to weaken the activity of caspase-1 that is normally essential for bacterial clearance and sepsis survival."

In another finding, researchers showed that both mouse models had similar levels of stress-induced apoptosis or programmed cell death. While caspase-12 was previously thought to be a key mediator of endoplasmic reticulum apoptosis, the new study found that the presence or absence of caspase-12 had no effect on apoptotic sensitivity whatsoever.

Others authors of the study include Maya Saleh (currently with McGill University), Melissa K. Wolinski, Steve J. Bensinger, Patrick Fitzgerald, Nathalie Droin, Douglas R. Green (La Jolla Institute of Allergy and Immunology and St. Jude Children's Research Hospital); Donald W. Nicholson of Merck Research Laboratories, and; John C. Mathison of Scripps Research.

Scripps Research Institute


Related Sepsis Current Events and Sepsis News Articles


Does sepsis keep killing months later?
It's known that many patients die in the months and years after sepsis.

Blood test uncovers undiagnosed diabetes in hospital patients with high blood sugar
A retrospective review of medical records found the HbA1C test, commonly used to diagnose and manage diabetes, can effectively detect hidden disease among hospital patients with hyperglycemia, commonly known as high blood sugar.

More than 10 risk factors identified in readmission of pediatric neurosurgery patients
Researchers at the University of Alabama at Birmingham have identified key risk factors associated with patient readmission within 30 days after pediatric neurosurgery in a recent study published in the Journal of Neurosurgery: Pediatrics.

Risk factors for unplanned hospital readmission following pediatric neurosurgery
Researchers at The University of Alabama at Birmingham have determined specific risk factors associated with hospital readmission following pediatric neurosurgery.

Two-minute video boosts pneumonia vaccinations
A simple two-minute video about pneumococcal vaccination sent to patients before a primary care visit tripled the likelihood they would get the vaccine, reports new Northwestern Medicine research. The vaccination can prevent severe disease from the bacteria that most commonly causes pneumonia and meningitis.

Does supplemental donor milk instead of formula reduce infections in preterm infants?
The combined incidence of serious infection, the intestinal disease necrotizing enterocolitis and death was similar in very low-birth-weight infants who received either pasteurized donor milk or preterm formula supplementation during their first 10 days of life when their own mother's milk was not sufficiently available.

Researchers discover potential treatment for sepsis and other responses to infection
Researchers at the Icahn School of Medicine at Mount Sinai say that tiny doses of a cancer drug may stop the raging, uncontrollable immune response to infection that leads to sepsis and kills up to 500,000 people a year in the U.S.

Cancer drug may treat sepsis, other uncontrollable immune responses to infection
Results from laboratory experiments and mouse studies suggest that small doses of drugs from a specific class of approved cancer medications called topoisomerase 1 (top1) inhibitors may protect against the overwhelming immune response to infection that sometimes leads to sepsis, a bacterial condition that kills as many as 500,000 people in the United States each year.

Immune study offers treatment hope for arthritis patients
Arthritis and other inflammatory conditions could be helped by new insights into how the immune response is switched off.

Genetic variation shown in patients with severe vascular complications of infection
Major infections such as influenza and bacterial sepsis kill millions of people each year, often resulting fro dangerous complications that impair the body's blood vessels.
More Sepsis Current Events and Sepsis News Articles

Sepsis: Diagnosis and Treatment

Sepsis: Diagnosis and Treatment
by NetCE


The purpose of this course is to provide healthcare professionals with evidence-based recommendations so they may optimally manage the patient who presents with sepsis and septic shock and minimize adverse outcomes. In addition, members of the public may use this course to enhance their personal knowledge of the subject matter presented.

Upon completion of this course, you should be able to:

1. Define the various degrees of sepsis, and describe the history and incidence of sepsis relative to mortality.
2. List the risk factors associated with the development of sepsis.
3. Describe the pathogenesis of SIRS, including the five phases of development, and the pathophysiology of sepsis.
4. List potential organ manifestations related to the...

My Sepsis Story: How I Almost Died and You Don't Have To

My Sepsis Story: How I Almost Died and You Don't Have To
by Lisa Brandt Creative Services


I am not a doctor. But when everyone, including a doctor, said I had the flu, I knew it was something more. I'm a survivor of sepsis. Chances are, you aren't familiar with sepis, but it kills more people than cancer and is more common than heart attack. And I want you to know about it so you can avoid what I went through. My story is anything but a Debbie Downer tale. After all, you already know it has a happy ending.

Sepsis

Sepsis


Rhys Ireland, a jack of all failures, stands on the precipice of suicide between the borders of Washington and Oregon; staring deep into the dark waters of the Columbia River at midnight. His next decision will change the world...irreparably.

The following morning, traveling to his favorite spot near Bonneville Dam, all retiree Graham Myers wants is an exciting day of sturgeon fishing Lord willing. The catch of the day proves entirely too exciting.

Nearby in the small town of North Bonneville, Trooper Janus Bradley, of the Washington State Patrol, is still bitter from the aftermath of a nasty divorce. Responding to a disturbance at the upscale hot springs resort, he bears witness to the beginning of the end.

Concurrently, fifteen year-old Aria...

Sepsis and Septic Shock

Sepsis and Septic Shock


Sepsis and Septic Shock

Last updated: 9/30/12, 5/21/13
Number of questions: 12

Sepsis: Diagnosis, Management and Health Outcomes (Allergies and Infectious Diseases)

Sepsis: Diagnosis, Management and Health Outcomes (Allergies and Infectious Diseases)
by Nancy, M.D., Ph.D. Khardori (Editor)




Sepsis

Sepsis
by Guillermo Ortiz-Ruiz (Editor), Marco A. Perafan (Editor), Eugen Faist (Editor), Carmelo Dueñas Castell (Editor)


Sepsis (or septic shock) is one of the leading post-surgical or post-traumatic complications in today's hospitals. This pervasive condition is the major cause of morbidity and mortality in intensive care units worldwide, as well as the leading cause of death in non-coronary patients. This is a concise, practical soft cover volume devoted to covering only the most practical information for physicians. Charts, tables, and other figures are used to illustrate easy-to-follow treatment guidelines for those professionals who regularly treat patients in the ICU.

Sepsis and Multiorgan Failure

Sepsis and Multiorgan Failure
by Alan M. Fein (Author), Fink (Author), Bone (Author)


This reference provides guidelines for management of infections in critically ill patients. It provides disease mechanisms of sepsis as well as clinical diagnosis, treatment and management, and the authors also explain the proper guidelines for assessment and treatment protocols in the ICU. They have designed this resource specifically to handle the common infectious problems. Included are evolving concepts from multiple pertinent disciplines such as: basic microbiology, outcome measures, pharmacology and epidemiology statistics.

Gyroscope- A Survival of Sepsis

Gyroscope- A Survival of Sepsis
by Gary Black (Author)


Gyroscope is a compelling and inspiring true story about a miraculous survival of sepsis. It reveals and illustrates the innermost traumas and triumphs of a journey through this devastating illness.

Actual book size is 6 x 9

The Sepsis Text

The Sepsis Text
by Jean-Louis Vincent (Editor), Jean Carlet (Editor), Steven M. Opal (Editor)


This textbook is written at the dawn of a new era in the management of sepsis. Recent achievements in the clinical management of septic shock are the culmination of decades of basic and applied research by innovative researchers and clinical investigators worldwide. The contributing authors to this book have spearheaded much of this research and the Editors have endeavored to create a textbook that is comprehensive in nature while maintaining a specific focus upon the multitude of work that constitutes the spectrum of sepsis research including: pathophysiology; monitoring systems; general support; microbial aspects; complications; and anti-sepsis therapies.

Five Weeks: a Lifetime: The True Journey of Clinton Jacob

Five Weeks: a Lifetime: The True Journey of Clinton Jacob


Suppose you have a teacher who knows the secret of life. A teacher who can show you what it takes to live to the fullest, to love until your heart bleeds out—to have it all, and then to let it all go. Now, suppose your teacher is only five weeks old.

When the Sullivans are told their unborn child has a congenital heart defect, they have no idea where the news will lead them. Their dreams of bedtime cuddles and soft baby coos give way to the incessant beeping of hospital machinery and the sharp smell of antiseptic. With two young children in tow, the uprooted family takes an unexpected journey discovering the truth of love, sorrow, and ultimately, the gift of life.

This true story—comprised of journal entries, letters, and emails—is the legacy of one small...

© 2016 BrightSurf.com